PMVP
Pmv Pharmaceuticals Inc
NASDAQ: PMVP · HEALTHCARE · BIOTECHNOLOGY
$1.39
-2.11% today
Updated 2026-04-29
Market cap
$74.13M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.48
Dividend yield
—
52W range
$1 – $2
Volume
0.7M
WallStSmart proprietary scores
30
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$4.75
+241.73%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-17.20M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-73.32M | $-68.96M | $-58.71M | $-77.74M | $-18.04M |
| EPS | — | — | — | — | $-1.48 |
| Free cash flow | $-71.74M | $-56.62M | $-51.94M | $-73.61M | $-17.20M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Pmv Pharmaceuticals Inc trades at $1.39. Our Smart Value Score of 30/100 indicates the stock is weak.
Frequently asked questions
What is Pmv Pharmaceuticals Inc's stock price?
Pmv Pharmaceuticals Inc (PMVP) trades at $1.39.
Is Pmv Pharmaceuticals Inc overvalued?
Smart Value Score 30/100 (Grade F, Strong Sell).
What is the price target of Pmv Pharmaceuticals Inc (PMVP)?
The analyst target price is $4.75, representing +241.7% upside from the current price of $1.39.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-55.40%
Beta1.40
50D MA$1.40
200D MA$1.34
Shares out0.05B
Float0.05B
Short ratio—
Avg volume0.7M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—